Stox
60
Bafna Pharmaceuticals Limited
NSE: BAFNAPH · Unclassified
₹454.50+1.55%06 Nov 2026
Ask the data
Instant answers about Bafna Pharmaceuticals Limited — computed from its filings, no language modelMarket cap₹1,075 cr
Current price₹454.50
High / Low₹471 / ₹99
P/E138.0
P/B11.18
Book value₹40.6
ROE8.1%
ROCE8.5%
Debt / equity0.39
Dividend yield—
EPS (TTM)₹3.29
Face value₹10
Price & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY09† | FY10† | FY11† | FY12† | FY13† | FY14† | FY15† | FY16† | FY17† | FY18† | FY19† | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 46.0 | 74.4 | 101.3 | 121.0 | 167.1 | 177.6 | 142.5 | 85.3 | 65.0 | 77.2 | 43.4 | 42.5 | 71.2 | 85.1 | 115.3 | 152.5 | 145.9 | 150.6 |
| EBITDA | 7.0 | 7.8 | 11.4 | 16.4 | 21.0 | 21.2 | 25.3 | 2.8 | -5.2 | -5.1 | -13.3 | 1.2 | 10.3 | 11.5 | 15.7 | 11.1 | 11.2 | 15.9 |
| Operating margin | 15.2% | 10.5% | 11.3% | 13.5% | 12.6% | 11.9% | 17.8% | 3.3% | -8.0% | -6.6% | -30.8% | 2.9% | 14.5% | 13.5% | 13.6% | 7.3% | 7.7% | 10.6% |
| Interest | 2.1 | 2.4 | 4.3 | 8.1 | 11.2 | 12.1 | 12.5 | 12.5 | 11.3 | 6.8 | 2.1 | 0.1 | 0.7 | 0.8 | 2.0 | 2.3 | 2.7 | 3.7 |
| Depreciation | 3.2 | 1.7 | 2.3 | 5.3 | 7.6 | 8.3 | 5.2 | 4.1 | 3.9 | 3.6 | 3.4 | 3.3 | 4.5 | 5.5 | 5.3 | 5.0 | 4.9 | 6.1 |
| Profit before tax | 3.1 | 4.1 | 4.7 | 5.4 | 5.2 | 2.2 | 6.1 | -12.5 | -19.3 | -14.3 | -18.2 | -25.2 | 5.8 | 5.2 | 11.6 | 7.3 | 4.2 | 11.0 |
| Tax | 2.1 | 1.6 | 0.0 | 3.3 | 1.3 | 0.9 | -0.0 | -0.3 | -0.8 | 2.2 | 1.5 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | -0.1 |
| Net profit | 1.1 | 2.5 | 4.7 | 2.1 | 3.9 | 1.3 | 6.1 | -12.2 | -18.5 | -16.5 | -19.7 | -25.2 | 5.8 | 5.2 | 11.3 | 7.3 | 4.2 | 11.1 |
| EPS ₹ | — | — | — | — | — | — | — | — | — | — | — | -106.54 | 2.46 | 4.34 | 4.86 | 3.11 | 1.76 | 4.69 |
| Operating cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | 6.5 | 5.0 | 9.5 | 22.1 | 15.4 |
| Capex | — | — | — | — | — | — | — | — | — | — | — | — | — | 7.5 | 6.7 | 15.6 | 21.9 | 24.9 |
| Dividend paid | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total assets | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 129.6 | 147.7 | 153.1 | 175.5 |
| Equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 73.5 | 80.8 | 84.8 | 96.2 |
Quarterly performance
last 73 quarters · ₹ crore| JUN '08† | SEP '08† | DEC '08† | MAR '09† | JUN '09† | SEP '09† | DEC '09† | MAR '10† | JUN '10† | SEP '10† | DEC '10† | MAR '11† | JUN '11† | SEP '11† | DEC '11† | MAR '12† | JUN '12† | SEP '12† | DEC '12† | MAR '13† | JUN '13† | SEP '13† | DEC '13† | MAR '14† | JUN '14† | SEP '14† | DEC '14† | MAR '15† | JUN '15† | SEP '15† | DEC '15† | MAR '16† | JUN '16† | SEP '16† | DEC '16† | MAR '17† | JUN '17† | SEP '17† | DEC '17† | MAR '18† | JUN '18† | SEP '18† | DEC '18† | MAR '19† | JUN '19† | SEP '19† | DEC '19† | MAR '20 | JUN '20 | SEP '20 | DEC '20 | MAR '21 | JUN '21 | SEP '21 | DEC '21 | MAR '22 | JUN '22 | SEP '22 | DEC '22 | MAR '23 | JUN '23 | SEP '23 | DEC '23 | MAR '24 | JUN '24 | SEP '24 | DEC '24 | MAR '25 | JUN '25 | SEP '25 | DEC '25 | MAR '26 | JUN '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.4 | 9.3 | 14.6 | 17.6 | 13.7 | 16.9 | 19.7 | 24.1 | 21.4 | 22.8 | 27.4 | 29.6 | 31.6 | 35.5 | 21.1 | 32.7 | 34.4 | 58.2 | 27.8 | 46.8 | 44.5 | 47.0 | 46.7 | 39.3 | 35.2 | 65.0 | 23.6 | 18.7 | 23.1 | 16.0 | 19.9 | 26.3 | 21.2 | 16.5 | 15.9 | 11.4 | 9.1 | 10.7 | 40.9 | 16.5 | 11.9 | 8.8 | 13.1 | 9.5 | 6.8 | 11.6 | 10.9 | 13.1 | 16.7 | 15.2 | 17.5 | 21.8 | 21.3 | 28.4 | 20.5 | 15.0 | 16.9 | 22.0 | 34.2 | 42.2 | 42.0 | 40.7 | 28.4 | 41.4 | 33.3 | 40.3 | 33.2 | 39.1 | 34.6 | 35.5 | 38.3 | 42.2 | 26.6 |
| Operating profit | 1.0 | 0.7 | 0.8 | 4.5 | 1.7 | 2.9 | 2.0 | 1.2 | 3.4 | 2.7 | 3.1 | 2.2 | 4.6 | 4.1 | 5.4 | 2.3 | 6.2 | 6.1 | 6.0 | 2.6 | 4.9 | 6.6 | 5.6 | 4.0 | 5.6 | 44.0 | -0.8 | -23.5 | 2.0 | 1.4 | 1.9 | -2.5 | 0.8 | 0.2 | -0.1 | -6.0 | -3.1 | 0.3 | 30.6 | -32.9 | -1.8 | 0.2 | 1.2 | -12.9 | -2.9 | -0.4 | 0.4 | 4.2 | 2.6 | 1.3 | 2.2 | 4.2 | 3.5 | 5.7 | 2.8 | -0.5 | 1.7 | 2.5 | 3.5 | 7.6 | 6.3 | 4.0 | -2.1 | 2.9 | 1.2 | 3.8 | 3.1 | 3.1 | 5.1 | 4.3 | 3.0 | 3.5 | 0.9 |
| Operating margin | 22.1% | 7.2% | 5.7% | 25.5% | 12.5% | 17.2% | 10.3% | 4.8% | 15.7% | 11.9% | 11.4% | 7.6% | 14.6% | 11.4% | 25.8% | 6.9% | 18.1% | 10.4% | 21.7% | 5.6% | 11.1% | 14.1% | 12.0% | 10.3% | 15.9% | 67.8% | -3.6% | -125.3% | 8.7% | 8.8% | 9.5% | -9.5% | 3.7% | 1.2% | -0.9% | -52.9% | -33.8% | 2.6% | 74.8% | -198.8% | -15.1% | 2.0% | 9.0% | -135.6% | -41.9% | -3.2% | 3.8% | 32.4% | 15.6% | 8.5% | 12.6% | 19.2% | 16.4% | 20.0% | 13.8% | -3.5% | 9.8% | 11.6% | 10.4% | 18.0% | 15.0% | 9.8% | -7.3% | 7.0% | 3.6% | 9.4% | 9.2% | 8.0% | 14.6% | 12.1% | 8.0% | 8.4% | 3.3% |
| Other income | 0.0 | 0.5 | 0.4 | 0.5 | 0.3 | 0.2 | 0.1 | 0.3 | 0.0 | — | 0.2 | 0.1 | 0.1 | 0.5 | 0.6 | 2.9 | 0.3 | 0.6 | 0.5 | 1.6 | 1.2 | -0.4 | 0.2 | 0.4 | 0.1 | 0.6 | -0.0 | 0.4 | 0.3 | 0.7 | 0.2 | 0.0 | 0.2 | 0.2 | 0.8 | -0.0 | 0.1 | 0.0 | 0.2 | 0.9 | 0.1 | -0.0 | 0.3 | 0.3 | 0.3 | 0.6 | 0.0 | -0.7 | 0.2 | 0.2 | 0.0 | 0.3 | 0.2 | 0.2 | 0.5 | 1.3 | 1.3 | 0.6 | 1.4 | 0.3 | 1.9 | 0.2 | 1.0 | 0.5 | 0.5 | 1.0 | 0.2 | 1.0 | 0.6 | 1.2 | 1.2 | 1.8 | 1.9 |
| Interest | 0.3 | 0.4 | 0.7 | 0.7 | 0.5 | 1.2 | 0.7 | 0.0 | 1.2 | 0.6 | 1.2 | 1.2 | 1.9 | 1.5 | 1.8 | 3.0 | 2.6 | 2.5 | 2.8 | 3.3 | 2.8 | 3.0 | 2.8 | 3.4 | 3.3 | 4.0 | 2.4 | 2.7 | 2.4 | 3.8 | 2.9 | 3.4 | 2.9 | 3.1 | 3.1 | 2.1 | 2.0 | 2.1 | 1.7 | 1.0 | 0.8 | 0.6 | 0.5 | 0.2 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.3 | 0.4 | 0.1 | 0.1 | 0.4 | 0.2 | 0.3 | 0.5 | 0.6 | 0.7 | 0.6 | 0.4 | 0.6 | 0.7 | 0.7 | 0.6 | 0.6 | 0.8 | 0.9 | 0.9 | 0.9 | 1.0 | 0.9 |
| Depreciation | 0.1 | 0.8 | 1.5 | 0.9 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.7 | 0.6 | 0.6 | 0.7 | 1.2 | 2.9 | 0.5 | 1.8 | 1.6 | 2.0 | 2.2 | 1.8 | 1.4 | 1.3 | 3.8 | 2.0 | 1.7 | 1.2 | 0.4 | 1.0 | 0.5 | 0.8 | 1.8 | 1.0 | 1.0 | 1.0 | 0.8 | 0.9 | 1.0 | 1.0 | 0.8 | 1.0 | 0.8 | 0.9 | 0.8 | 1.0 | 0.7 | 1.0 | 0.5 | 0.9 | 1.0 | 1.0 | 1.5 | 1.5 | 1.4 | 1.2 | 1.4 | 1.3 | 1.1 | 1.4 | 1.5 | 1.2 | 1.2 | 1.3 | 1.3 | 1.4 | 1.6 | 1.7 | 0.2 | 1.4 | 1.5 | 1.6 | 1.7 | 1.8 |
| Profit before tax | 0.7 | 0.0 | -1.0 | 3.4 | 1.1 | 1.2 | 0.8 | 0.9 | 1.6 | 1.3 | 1.3 | 0.5 | 1.9 | 1.7 | 1.2 | 0.5 | 2.1 | 2.5 | 1.8 | -1.2 | 1.6 | 1.8 | 1.7 | -2.8 | 0.4 | 36.3 | -4.5 | -26.1 | -1.1 | -2.2 | -1.6 | -7.7 | -3.0 | -3.8 | -3.5 | -9.1 | -5.9 | -2.8 | 28.1 | -33.7 | -3.5 | -1.2 | 0.1 | -13.6 | -3.7 | -0.6 | -22.4 | 1.4 | 1.8 | 0.5 | 0.9 | 2.6 | 2.1 | 2.4 | 1.7 | -1.0 | 1.4 | 1.6 | 3.0 | 5.7 | 6.3 | 2.5 | -2.9 | 1.5 | -0.7 | 2.6 | 0.9 | 1.3 | 3.4 | 3.1 | 1.8 | 2.6 | 0.1 |
| Tax | 0.1 | 0.3 | 0.1 | 1.6 | 0.1 | 0.0 | 0.0 | 1.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.2 | -0.5 | 2.6 | 1.1 | 0.5 | 0.3 | -0.6 | 0.5 | 0.6 | 0.6 | -0.8 | 0.1 | 3.1 | 0.1 | -3.3 | 0.1 | 0.2 | 0.2 | -0.8 | -0.1 | -0.1 | -0.1 | -0.7 | 1.7 | 0.0 | 0.0 | 0.5 | -0.0 | 0.1 | 0.0 | 1.5 | -1.6 | 0.0 | -0.0 | 1.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 |
| Net profit | 0.6 | -0.2 | -1.1 | 1.8 | 1.0 | 1.2 | 0.8 | -0.6 | 1.6 | 1.3 | 1.3 | 0.5 | 1.9 | 0.5 | 1.8 | -2.1 | 1.1 | 2.1 | 1.4 | -0.7 | 1.1 | 1.2 | 1.1 | -2.0 | 0.3 | 33.2 | -4.7 | -22.8 | -1.2 | -2.4 | -1.7 | -6.8 | -2.9 | -3.8 | -3.4 | -8.4 | -7.6 | -2.8 | 28.1 | -34.2 | -3.5 | -1.3 | 0.1 | -15.1 | -2.1 | -0.6 | -22.3 | -0.2 | 1.8 | 0.5 | 0.9 | 2.6 | 2.1 | 2.4 | 1.7 | -1.0 | 1.4 | 1.6 | 3.0 | 5.4 | 6.3 | 2.5 | -2.9 | 1.5 | -0.7 | 2.6 | 0.9 | 1.3 | 3.4 | 3.1 | 1.8 | 2.8 | 0.1 |
| EPS ₹ | 0.60 | -0.15 | 0.70 | 1.22 | 0.60 | 0.77 | 0.53 | -0.35 | 1.00 | 0.81 | 0.83 | 0.30 | 1.11 | 0.26 | 1.01 | -1.14 | 0.58 | 1.11 | 0.75 | -0.35 | 0.56 | 1.20 | 1.79 | -1.08 | 0.17 | 17.81 | -2.49 | -12.21 | -0.64 | -1.29 | -0.93 | -3.67 | -1.55 | -2.01 | -1.85 | -4.49 | -4.08 | -1.48 | 15.06 | -14.44 | -1.49 | -0.54 | 0.05 | -6.37 | -0.90 | 0.25 | -94.39 | -0.66 | 7.66 | 0.20 | 0.38 | 1.11 | 0.88 | 0.95 | 0.72 | -0.76 | 0.57 | 0.68 | 1.26 | 2.34 | 2.68 | 1.05 | -1.24 | 0.62 | -0.31 | 1.11 | 0.40 | 0.55 | 1.43 | 1.32 | 0.78 | 1.16 | 0.03 |
| Revenue YoY | — | — | — | — | 208.6% | 81.5% | 35.0% | 36.6% | 56.6% | 35.1% | 39.0% | 22.9% | 47.4% | 55.9% | -23.2% | 10.6% | 8.6% | 63.7% | 31.9% | 43.0% | 29.7% | -19.2% | 68.1% | -16.0% | -20.9% | 38.2% | -49.4% | -52.4% | -34.4% | -75.4% | -15.6% | 40.4% | -8.5% | 3.1% | -20.3% | -56.5% | -57.0% | -35.2% | 157.6% | 44.4% | 31.3% | -17.2% | -68.0% | -42.5% | -42.7% | 30.9% | -16.4% | 38.2% | 143.8% | 31.4% | 59.9% | 66.3% | 27.3% | 87.1% | 17.0% | -31.4% | -20.4% | -22.8% | 67.3% | 182.0% | 147.8% | 85.2% | -16.9% | -2.0% | -20.6% | -0.9% | 16.7% | -5.7% | 4.0% | -12.0% | 15.4% | 8.1% | -23.2% |
| Profit YoY | — | — | — | — | 62.7% | — | — | -131.0% | 65.6% | 4.0% | 56.5% | — | 22.0% | -65.1% | 33.1% | -494.3% | -45.4% | 360.0% | -20.3% | — | -0.9% | -42.5% | -22.0% | — | -70.5% | 2691.6% | -522.7% | — | -483.9% | -107.3% | — | — | — | — | — | — | — | — | — | — | — | — | -99.6% | — | — | — | -18708.3% | — | — | — | — | — | 15.5% | 395.8% | 88.9% | -138.3% | -34.9% | -32.4% | 75.9% | — | 366.9% | 54.0% | -198.3% | -72.8% | -111.3% | 5.6% | — | -10.3% | — | 19.1% | 93.7% | 109.9% | -97.6% |
Returns & margins
trailing-twelve-month, per quarter| MAR '09 | JUN '09 | SEP '09 | DEC '09 | MAR '10 | JUN '10 | SEP '10 | DEC '10 | MAR '11 | JUN '11 | SEP '11 | DEC '11 | MAR '12 | JUN '12 | SEP '12 | DEC '12 | MAR '13 | JUN '13 | SEP '13 | DEC '13 | MAR '14 | JUN '14 | SEP '14 | DEC '14 | MAR '15 | JUN '15 | SEP '15 | DEC '15 | MAR '16 | JUN '16 | SEP '16 | DEC '16 | MAR '17 | JUN '17 | SEP '17 | DEC '17 | MAR '18 | JUN '18 | SEP '18 | DEC '18 | MAR '19 | JUN '19 | SEP '19 | DEC '19 | MAR '20 | JUN '20 | SEP '20 | DEC '20 | MAR '21 | JUN '21 | SEP '21 | DEC '21 | MAR '22 | JUN '22 | SEP '22 | DEC '22 | MAR '23 | JUN '23 | SEP '23 | DEC '23 | MAR '24 | JUN '24 | SEP '24 | DEC '24 | MAR '25 | JUN '25 | SEP '25 | DEC '25 | MAR '26 | JUN '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 5.6% | 7.5% | 15.4% | 22.2% | 20.9% | 13.7% | 9.1% | 0.3% | 0.5% | 5.2% | 4.9% | 9.8% | 9.6% | 10.6% | 11.5% | 8.1% |
| ROCE | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 5.8% | 7.5% | 14.2% | 19.6% | 20.0% | 14.0% | 9.2% | 2.5% | 2.9% | 6.8% | 6.1% | 10.0% | 9.7% | 10.6% | 11.0% | 8.5% |
| Net margin | 2.3% | 2.6% | 4.7% | 7.2% | 3.3% | 3.8% | 3.6% | 3.8% | 4.7% | 4.6% | 3.4% | 4.0% | 1.7% | 1.0% | 1.9% | 1.6% | 2.3% | 2.2% | 1.8% | 1.4% | 0.7% | 0.4% | 17.5% | 16.5% | 4.3% | 3.5% | -38.1% | -36.1% | -14.3% | -16.7% | -18.2% | -21.2% | -28.4% | -43.8% | -47.1% | 13.0% | -21.3% | -15.4% | -13.9% | -77.1% | -45.5% | -48.0% | -43.1% | -103.2% | -59.3% | -40.6% | -36.1% | 4.8% | 8.2% | 8.1% | 9.0% | 9.6% | 6.1% | 5.5% | 4.9% | 5.6% | 9.8% | 11.6% | 10.8% | 7.3% | 4.8% | 0.2% | 0.3% | 2.9% | 2.9% | 5.6% | 6.2% | 6.6% | 7.4% | 5.5% |
| EBITDA margin | 15.2% | 14.0% | 15.8% | 16.4% | 10.5% | 11.5% | 10.5% | 10.8% | 11.3% | 11.4% | 11.3% | 13.9% | 13.5% | 14.5% | 13.7% | 13.5% | 12.6% | 11.1% | 12.2% | 10.7% | 11.9% | 13.0% | 31.8% | 32.4% | 17.8% | 16.7% | -25.7% | -23.4% | 3.3% | 1.9% | 0.4% | -2.1% | -8.0% | -17.2% | -19.1% | 30.1% | -6.6% | -4.7% | -5.0% | -66.1% | -30.8% | -37.6% | -36.5% | -40.4% | 3.4% | 13.2% | 15.3% | 16.6% | 14.5% | 14.8% | 17.5% | 17.6% | 13.5% | 12.0% | 8.8% | 8.2% | 13.3% | 14.3% | 13.5% | 10.3% | 7.3% | 4.2% | 4.1% | 7.4% | 7.7% | 10.2% | 10.9% | 10.5% | 10.6% | 8.2% |
| Debt / equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.30 | 0.30 | 0.31 | 0.31 | 0.20 | 0.20 | 0.30 | 0.30 | 0.23 | 0.23 | 0.33 | 0.33 | 0.36 | 0.36 | 0.39 | 0.39 |
| Interest coverage | 2.53 | 2.57 | 2.54 | 3.18 | 2.72 | 2.46 | 2.85 | 2.65 | 2.10 | 2.03 | 1.94 | 1.84 | 1.66 | 1.63 | 1.64 | 1.63 | 1.46 | 1.40 | 1.32 | 1.32 | 1.18 | 1.09 | 3.62 | 3.23 | 1.49 | 1.39 | -2.01 | -1.64 | -0.00 | -0.10 | -0.29 | -0.42 | -0.70 | -1.14 | -1.27 | 2.31 | -1.10 | -1.11 | -1.47 | -12.09 | -7.59 | -11.94 | -20.08 | -82.73 | -83.00 | -102.58 | -108.71 | 12.53 | 8.77 | 8.27 | 9.61 | 9.72 | 7.45 | 5.43 | 3.73 | 4.30 | 6.72 | 8.16 | 8.56 | 5.97 | 4.20 | 1.12 | 1.17 | 2.66 | 2.52 | 3.77 | 3.72 | 3.80 | 4.00 | 3.08 |
| Asset turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.70 | 0.83 | 0.89 | 1.08 | 1.18 | 1.14 | 1.03 | 0.97 | 1.07 | 1.10 | 0.95 | 0.96 | 0.89 | 0.92 | 0.86 | 0.81 |
Balance sheet
equity vs borrowings over time · ₹ crore| SEP '22 | MAR '23 | SEP '23 | MAR '24 | SEP '24 | MAR '25 | SEP '25 | MAR '26 | |
|---|---|---|---|---|---|---|---|---|
| Share capital | 23.7 | 23.7 | 23.7 | 23.7 | 23.7 | 23.7 | 23.7 | 23.7 |
| Other equity / reserves | 42.2 | 49.8 | 58.7 | 57.2 | 59.1 | 61.1 | 67.6 | 72.5 |
| Total equity | 65.8 | 73.5 | 82.4 | 80.8 | 82.8 | 84.8 | 91.2 | 96.2 |
| Borrowings | 20.0 | 22.9 | 16.6 | 24.4 | 18.8 | 28.2 | 32.4 | 37.4 |
| Current liabilities | 33.8 | 46.5 | 44.2 | 54.1 | 38.0 | 51.9 | 47.8 | 57.2 |
| Non-current liabilities | 6.6 | 9.7 | 8.3 | 12.8 | 13.4 | 16.4 | 21.6 | 22.2 |
| Total assets | 106.2 | 129.6 | 134.9 | 147.7 | 134.2 | 153.1 | 160.7 | 175.5 |
| Property, plant & equipment | 40.9 | 40.2 | 39.1 | 40.2 | 54.0 | 58.8 | 65.0 | 81.8 |
| Capital work-in-progress | 1.9 | 1.5 | 1.8 | 10.5 | 1.6 | 7.3 | 14.7 | 3.1 |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventories | 21.6 | 22.2 | 29.4 | 29.6 | 27.5 | 28.1 | 31.0 | 28.9 |
| Receivables | 21.0 | 41.1 | 39.8 | 45.4 | 33.7 | 40.2 | 32.6 | 43.9 |
| Cash & equivalents | 3.5 | 7.8 | 7.9 | 1.4 | 1.3 | 3.4 | 0.2 | 2.0 |
Cash flow
annual · ₹ crore · line = free cash flow| FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Cash from operations | 6.5 | 5.0 | 9.5 | 22.1 | 15.4 |
| Cash from investing | -4.5 | -7.5 | -15.1 | -21.2 | -22.4 |
| Cash from financing | -3.6 | 10.2 | -0.8 | 1.1 | 5.6 |
| Capex | 7.5 | 6.7 | 15.6 | 21.9 | 24.9 |
| Free cash flow | -1.0 | -1.8 | -6.1 | 0.3 | -9.5 |
| Dividends paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Where the assets sit
Mar '26 · ₹ croreFixed assets (PPE)₹81.8 cr47%
CWIP₹3.1 cr2%
Inventories₹28.9 cr16%
Receivables₹43.9 cr25%
Cash & equivalents₹2.0 cr1%
Other assets₹15.8 cr9%
Peer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Bafna Pharmaceuticals Limited | 1,075 | 454.50 | 138.0 | 11.18 | 8.1% |
StoxGud checklist: Neutral setup · 6/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
1 month+13.1%
6 months+246.4%
1 year+229.2%
3Y CAGR+75.3%
5Y CAGR+28.5%
10Y CAGR—
50-day avg₹375.79
200-day avg₹214.78
RSI (14)47
FAQs
What is the share price of Bafna Pharmaceuticals Limited?
Bafna Pharmaceuticals Limited (BAFNAPH) closed at ₹454.50 on NSE on 06 Nov 2026.
What is the market cap of Bafna Pharmaceuticals Limited?
₹1,075 crore at the latest close.
What is the P/E ratio of Bafna Pharmaceuticals Limited?
138.0, on trailing-twelve-month earnings from its filings.
How fast is Bafna Pharmaceuticals Limited growing?
Bafna Pharmaceuticals Limited: revenue has compounded at 9.3% a year over three years; net profit at -0.7% a year. Latest-quarter revenue is down 23.2% year on year, profit down 97.6%.
How profitable is Bafna Pharmaceuticals Limited?
On a trailing-twelve-month basis return on equity is 8.1%, return on capital employed 8.5%, operating margin 8.2%, net margin 5.5%.
How much debt does Bafna Pharmaceuticals Limited have?
Bafna Pharmaceuticals Limited is lightly geared: debt to equity is 0.39 with borrowings of ₹37 cr against cash of ₹2 cr (balance sheet of 2026-03-31). Operating profit covers interest 3.1 times.
Financials parsed from Bafna Pharmaceuticals Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Quarterly from JUN '08, annual from FY09, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). † = the company's standalone results as published on BSE, used for quarters before MAR '20 (full years marked † are summed from them); cross-checked against the NSE filings where both exist. Information only, not investment advice.
Bafna Pharmaceuticals Limited · advanced chart